$23.69
-28.83 (-54.89%)
Performance
1D
—
1W
-52.63%
1M
-45.11%
3M
-48.80%
6M
-40.33%
1Y
-43.18%
YTD
-44.11%
Open$33.83
Previous Close$52.52
Day High$33.84
Day Low$21.91
52W High$60.91
52W Low$29.46
Volume—
Avg Volume1.20M
Market Cap4.10B
P/E Ratio35.82
EPS$1.40
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$44.90
Below
SMA 200
$42.96
Below
RSI (14)
73.4
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+97.8% upside
Current
$23.69
$23.69
Target
$46.85
$46.85
$30.44
$46.85 avg
$57.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 523.17M | 434.64M | 507.99M |
| Net Income | 67.13M | 50.19M | -2,027,984 |
| Profit Margin | 12.8% | 12.2% | -0.4% |
| EBITDA | 66.45M | 52.44M | -2,983,128 |
| Free Cash Flow | — | — | -1,866,923 |
| Rev Growth | +20.4% | +20.4% | +16.6% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.34 | +1.08% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $461.10 | +0.18% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $168.18 | +0.36% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $546.92 | +0.81% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $908.12 | +0.58% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $157.53 | +0.56% | 28.8 | 23.28B |